Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia-Reference-Cited by-同舟云学术

Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia

Published:2005-07 Issue:1 Volume:193 Page:153-163
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Magee Laura A.,Miremadi Saman,Li Jing,Cheng Carol,Ensom Mary H.H.,Carleton Bruce,Côté Anne-Marie,von Dadelszen Peter

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference26 articles.

1. Report of the Canadian Hypertension Society Consensus Conference: 3, pharmacologic treatment of hypertensive disorders in pregnancy;Rey;CMAJ,1997

2. The detection, investigation and management of hypertension in pregnancy: executive summary;Brown;Aust N Z J Obstet Gynaecol,2000

3. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy;Am J Obstet Gynecol,2000

4. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade;Ben Ami;Br J Obstet Gynaecol,1994

5. Neuromuscular blockade with magnesium-sulfate and nifedipine;Snyder;Am J Obstet Gynecol,1989

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertensive Disorders of Pregnancy: Diagnosis, Management and Timing of Birth;Balkan Medical Journal;2024-09-06

2. Fluid and Electrolyte Balance;Critical Care Obstetrics;2024-04

3. Hypertensive Disorders of Pregnancy;Peripartum Care of the Pregnant Patient;2024

4. Hypertension in Pregnancy;Hypertension;2024

5. Abnormale Plazentation: Hypertensive Schwangerschaftserkrankungen;Springer Reference Medizin;2024